Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Companies / Germany

Astellas Cuts German Investment

August 2007 | Company Finance Alert

Japanese drugmaker Astellas has announced that it is to cutback it operations in Germany becoming the latest sector player to disinvest in the country. Germany currently places third in BMI 's business Environment matrix for the Western European region but further divestments could result in a fall in the rankings.

Sorry, you must be a subscriber to view this article in full. If you are a subscriber please login.

[
: *
[
: *

Forgotten your password?

If you would like to subscribe to Asia Pacific Pharma & Healthcare Insight and gain instant access to this article, please click here to subscribe.

If you would like to take a trial to Asia Pacific Pharma & Healthcare Insight please click on the trial link below.

Free Trial To Pharmaceuticals & Healthcare Insight

TAKE A TRIAL >>
Related Insight Articles
Dabur Sells Anticancer Business

Industry / Germany Indian company Dabur India has sold its pharmaceutical division to German healthcare firm Fresenius Kabi. The asset mainly sells generic anticancer agents, and the purchase price was INR872 crore (US$219mn)....
April 2008
Ranbaxy Gets Products Listed On AOK

Companies / Germany The German subsidiary of Indian generic drugmaker Ranbaxy has announced that a number of its products have been selected by 16 Allgemeine Ortskrankenkassen (AOK), the country's largest health insurance...
February 2007
Drugmakers Look To India

Companies / Germany German drugmakers are increasingly looking to set up both production and R&D operations in India because of a deteriorating domestic business environment. Since India offers a low cost base, skilled...
November 2006
Multinationals Eye Japan's Cancer Market

Companies / Japan According to industry experts, prospects for a significant expansion of Japan's US$3.2bn cancer market are set to improve significantly. New product launches by foreign-owned companies, and a health...
August 2006
Boehringer Japan Outpaces Competitors In 2005

Companies / Germany Elsewhere, Chugai, the Japanese affiliate of Swiss pharmaceutical major Roche, has filed a submission for colorectal cancer drug Avastin (bevacizumab) with the health ministry. A new ministry committee...
April 2006


All material on this site is protected by international copyright laws and use of this site is subject to our Terms & Conditions.
© 2009 Business Monitor International Ltd
Site powered by WORKSsitebuilder CMS